Recap: AtriCure Q4 Earnings

AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:01 PM. Here’s what investors…

byBenzinga Insights

February 15, 2024

1 minute read

AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:01 PM.

Here’s what investors need to know about the announcement.

Earnings

AtriCure beat estimated earnings by 8.7%, reporting an EPS of $-0.21 versus an estimate of $-0.23.

Revenue was up $18.52 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 4.48% increase in the share price the next day.

Here’s a look at AtriCure’s past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.31	-0.29	-0.34	-0.18
EPS Actual	-0.20	-0.12	-0.23	-0.09
Revenue Estimate	96.73M	97.49M	87.53M	87.66M
Revenue Actual	98.29M	100.92M	93.49M	88.03M

To track all earnings releases for AtriCure visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Science 37 Holdings, Inc. – Common Stock Q2 Sales $19.30M Miss $19.49M Estimate

By Benzinga Newsdesk

August 11, 6:07 AM

Science 37 Holdings, Inc. - Common Stock (NASDAQ:SNCE) reported quarterly sales of $19.30 million which missed the analyst consensus estimate of $19.49 million by 0.97 percent.

SNCE

S&P 500 Snaps 5-Session Losing Streak But Investor Sentiment Eases

By Lisa Levin

December 9, 4:08 AM

The CNN Money Fear and Greed index showed slight easing in the market sentiment despite US stocks recording gains on Thursday. The S&P 500 closed higher in the previous session, ending its longest losing streak since October. Data released Thursday showed a modest rise in jobless claims, with continuing claims reaching their highest level since February.

GME

The Trade Desk Stock Climbs After Mixed Q4 Results, Expanded Share Repurchase

By Erica Kollmann

February 15, 5:37 PM

The Trade Desk reported quarterly earnings of 41 cents per share which missed the analyst consensus estimate of 43 cents by 4.65%. The company reported quarterly sales of $605.8 million, beating the analyst consensus estimate of $582.17 million by 4.06% and representing a 23.45% increase over sales of $490.74 million from the same period last year.

TTD